Gencor Industries is currently trading at a significant discount compared to its book value and EV/EBITDA multiples relative to its peers. The company has a strong financial position, holding $136.3 million in cash and no debt against a market cap of $197.2 million, which reduces its risk profile despite mixed cash flow and slow market growth. Analyst Daniel Jones rates Gencor as a "Strong Buy," projecting potential upside from 50% to over 300% if valuation gaps with competitors close. This makes Gencor an attractive investment opportunity for value-focused investors seeking companies with solid liquidity and undervalued assets.
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
